Status:
COMPLETED
Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Deep Venous Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Severe SARS-CoV-2 infection, responsible of COVID-19, is accompanied by many venous thromboembolic events. Antithrombotic treatment is the cornerstone of management of many neurovascular diseases (NVD...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age\>18 years
- COVID-19 confirmed with RT-PCER and/or chest CT-scan
- Acute neurovascular disease defined as transient ischemic attack or acute ischemic stroke or venous cerebral thrombosis or hemorrhagic stroke.
- Exclusion criteria:
- age\<18
- Other neurovascular diseases
Exclusion
Key Trial Info
Start Date :
June 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 23 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04452422
Start Date
June 23 2020
End Date
September 23 2020
Last Update
October 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Unité Neurovasculaire
Strasbourg, France, 67091